Allen Esterson wrote: > Another view on the current debate: > > http://www.blackdoginstitute.org.au/docs/Antideps27Feb08.pdf > > Note that the key lines here are anecdotal (and precisely mimic the talking points that the drug companies themselves have emitted over the past couple of weeks):
"most people suffering clinical depression and, in particular, melancholic depression (the 'Black Dog') who take antidepressants, find them strikingly effective." "the study attracting media attention was based on trials of antidepressant drugs in people whose conditions did not correspond with clinical depression as seen by health practitioners" Of course neither the patients nor the health practitioners have any way of distinguishing real from placebo effects, which is precisely why we need double blind clinical trials, and why the study they are trying to undermine is far more credible than their informal clinical impressions. By the way, does anyone know what connections Gordon Parker might have to the pharmaceutical industry? Regards, -- Christopher D. Green Department of Psychology York University Toronto, ON M3J 1P3 Canada 416-736-2100 ex. 66164 [EMAIL PROTECTED] http://www.yorku.ca/christo/ "Part of respecting another person is taking the time to criticise his or her views." - Melissa Lane, in a /Guardian/ obituary for philosopher Peter Lipton ================================= --- To make changes to your subscription contact: Bill Southerly ([EMAIL PROTECTED])
